Expression of a translationally regulated, dominant-negative CCAAT/enhancer-binding protein beta isoform and up-regulation of the eukaryotic translation initiation factor 2alpha are correlated with neoplastic transformation of mammary epithelial cells.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 8813130.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A translationally regulated, dominant-negative isoform of CCAAT/enhancer-binding protein beta is expressed in transplantable and primary mouse mammary tumors of different etiologies but is not expressed in preneoplastic mammary hyperplasias or in primary prostate, lung, lens, ovary or lymphoid tumors. The eukaryotic initiation factor 2alpha protein is also expressed at significantly higher levels (69.8 +/- 7.2%) in these mammary tumors compared with normal and hyperplastic tissues. Thus, misregulation of eukaryotic initiation factor 2alpha may promote the expression of a dominant-negative CCAAT/enhancer-binding protein beta isoform, which may inhibit terminal differentiation and facilitate uncontrolled proliferation of mammary epithelial cells.
Medical subject headings
- Cell Transformation, Neoplastic
- DNA-Binding Proteins
- Eukaryotic Initiation Factor-2
- Gene Expression Regulation, Neoplastic
- Mammary Glands, Animal
- Mammary Neoplasms, Experimental
- Neoplasm Proteins
- Nuclear Proteins
- Precancerous Conditions
- Protein Biosynthesis